31 – 40 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)
(
- Contribution to journal › Article
-
Mark
S100A9 and tumor growth.
(
- Contribution to journal › Article
- 2011
-
Mark
Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia
(
- Contribution to journal › Article
-
Mark
Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: Block of initiation of proliferation of Gr-1(+) cells.
(
- Contribution to journal › Article
- 2010
-
Mark
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
(
- Contribution to journal › Article
-
Mark
Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
(
- Contribution to journal › Article
-
Mark
Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757.
(
- Contribution to journal › Article
- 2009
-
Mark
From the fetal liver to spleen and gut: the highway to natural antibody
(
- Contribution to journal › Article
-
Mark
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.
(
- Contribution to journal › Article